Peripheral nervous system damage in coronavirus infection: research results

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

SARS-CoV-2 coronavirus has the ability to affect the nervous system and cause various neurologic disorders, both in the acute period and after recovery or during the development of post-coital syndrome. Among the nosologic forms of peripheral nervous system lesions after a new coronavirus infection are mononeuropathies, multineuropathies, multiple neuropathies, and noninflammatory polyneuropathies. Both the debut of neurological disease with varying degrees of severity of symptoms, including disabling, and progression of the existing pathology, requiring a change in treatment tactics, are possible. The article presents the results of a prospective study evaluating the effect of COVID-19 on the peripheral nervous system. Recommendations for physicians on the management of patients with peripheral nervous system damage against the background of coronavirus infection developed on the basis of the obtained information are presented.

作者简介

N. Amosova

North-Western district scientific and clinical center named after L.G. Sokolov; Almazov National Medical Research Centre

编辑信件的主要联系方式.
Email: rebecca_aleks@mail.ru
ORCID iD: 0000-0002-3178-8393
俄罗斯联邦, Saint Petersburg; Saint Petersburg

S. Kucherenko

North-Western district scientific and clinical center named after L.G. Sokolov; Almazov National Medical Research Centre

Email: rebecca_aleks@mail.ru
ORCID iD: 0000-0001-8258-094X

MD; Professor

俄罗斯联邦, Saint Petersburg; Saint Petersburg

V. Ratnikov

North-Western district scientific and clinical center named after L.G. Sokolov; Saint-Petersburg State University

Email: rebecca_aleks@mail.ru
ORCID iD: 0000-0002-9645-8408

MD; Professor 

俄罗斯联邦, Saint Petersburg; Saint Petersburg

T. Alekseeva

Almazov National Medical Research Centre

Email: rebecca_aleks@mail.ru
ORCID iD: 0000-0002-4441-1165

MD

俄罗斯联邦, Saint Petersburg

参考

  1. Cabañes-Martinez L., Villadóniga M., González-Rodriguez L. et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2020; 131 (12): 2809–16. doi: 10.1016/j.clinph.2020.09.017
  2. Paliwal V.K., Garg R.K., Gupta A. et al. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020; 41 (11): 3039–56. doi: 10.1007/s10072-020-04708-8
  3. Maury A., Lyoubi A., Peiffer-Smadja N. et al. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris). 2020; 2002: 30732–3. doi: 10.1016/j.neurol.2020.10.001
  4. Domingues R.B., Mendes-Correa M.C., de Moura Leite F.B.V. et al. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. J Neurol. 2020; 267 (11): 3154–6. doi: 10.1007/s00415-020-09996-w
  5. Wang K., Chen W., Zhang Z. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020; 5 (1): 283. doi: 10.1038/s41392-020-00426-x
  6. Хронический болевой синдром (ХБС) у взрослых пациентов, нуждающихся в паллиативной медицинской помощи. Клинические рекомендации. М.: Минздрав России, 2018 [Chronic pain syndrome (CPS) in adult patients requiring palliative care. Clinical recommendations. Moscow: Ministry of Health of Russia, 2018 (in Russ.)].
  7. Bouhassira D., Attal N., Fermanian J. et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004; 108 (3): 248–57. doi: 10.1016/j.pain.2003.12.024
  8. Bouhassira D. Le questionnaire DN4: Le nouvel outil d’aide au diagnostic des douleurs neuropathiques. Douleurs: Evaluation-Diagnostic-Traitement. 2005; 6: 297–300. doi: 10.1016/S1624-5687(05)80288-4
  9. Давыдов О.С., Яхно Н.Н., Кукушкин М.Л. и др. Невропатическая боль: клинические рекомендации по диагностике и лечению Российского общества по изучению боли. Российский журнал боли. 2018; 4: 5–41 [Davydov O.S., Yakhno N.N., Kukushkin M.L. et al. Neuropathic pain: clinical guidelines for the diagnosis and treatment of the Russian Society for the Study of Pain. Rossiyskiy zhurnal boli. 2018; 4: 5–41 (in Russ.)]. doi: 10.25731/RASP.2018.04.025
  10. Freynhagen R., Baron R., Gockel U. et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006; 22 (10): 1911–20. doi: 10.1185/030079906X132488
  11. Андрющенко А.В., Дробижев М.Ю., Добровольский А.В. Сравнительная оценка шкал CES-D, BDI и HADS(d) в диагностике депрессий в общемедицинской практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2003; 103 (5): 11–8 [Andriushchenko A.V., Drobizhev M.Iu., Dobrovol'skii A.V. A comparative validation of the scale CES-D, BDI, and HADS(d) in diagnosis of depressive disorders in general practice. Zh Nevrol Psikhiatr Im S S Korsakova. 2003; 103 (5): 11–8 (in Russ.)].
  12. Попов В.В., Трохова М.В., Новикова И.А. Депрессивные расстройства в общей врачебной практике. СПб: СпецЛит, 2017 [Popov V.V., Trokhova M.V., Novikova I.A. Depressive disorders in general medical practice. SPb: SpetsLit, 2017 (in Russ.)].

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 1. Severity of peripheral nervous system damage according to motor and sensory neuropathy severity criteria he severity of nerve lesions in patients

下载 (61KB)
索引源数据
3. Fig. 2. Localization of nerve lesions in patients

下载 (129KB)
索引源数据
4. Fig. 3. Lesions of motor and sensitive nerve fibers

下载 (70KB)
索引源数据
5. Fig. 4. Sensory disturbances depending on the severity of COVID-19

下载 (64KB)
索引源数据
6. Fig. 5. Pain severity in visual analog scale depending on the severity of COVID-19

下载 (65KB)
索引源数据
##common.cookie##